Future Medicine Co., Ltd. (XKON: 341170)

Market Cap	17.62B
Revenue (ttm)	1.00B
Net Income (ttm)	-13.37B
Shares Out	9.28M
EPS (ttm)	-1,637.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,681
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1,900.00 - 8,960.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 26
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 341170